Search results for IKK

IKK beta (L570) Antibody#2678, Cell Signaling Technology (CST), 2678

IKK beta (L570) Antibody detects endogenous levels of total IKKβ protein.

IKK alpha/beta Antibody (YA1871), MedChemexpress, HY-P82126

IKK alpha/beta Antibody (YA1871) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to IKK alpha/beta.

IKK gamma (N-Terminus) antibody, Covalab, Ref 00097886

IKK epsilon (C-Terminus) antibody, Covalab, Ref 00097885

HRP Anti-IKK alpha antibody [Y463], Abcam, AB200415

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

HRP Anti-IKK beta antibody [EPR6043], Abcam, AB305402

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

HRP Anti-IKK beta antibody [Y466], Abcam, AB194713

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

IKK beta Antibody (YA7184)(PBS only), MedChemexpress, HY-P87500A

IKK beta Antibody (YA7184) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to IKK beta.

IKK alpha (phospho Ser176/Ser180) antibody, Genetex, GTX17943

APC Anti-IKK alpha antibody [Y463], Abcam, AB221910

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .